Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia

European Journal of Endocrinology

Volumn 163, Issue 3, 2010, Pages 369-376

  Occhi, G ^a   Trivellin, G ^a   Ceccato, F ^a   De Lazzari, P ^a   Giorgi, G ^b   Dematte S ^c   Grimaldi, F ^d   Castello, R ^e   Davi M V ^f   Arnaldi, G ^g   Salviati, L ^b   Opocher, G ^a,h   Mantero, F ^a   Scaroni, C ^a  

^a Institute of Semeiotica Medica   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

^e Division of Endocrinology and Metabolic Diseases   (Italy)

^f UNIVERSITY OF VERONA   (Italy)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^h VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROLACTIN; PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; COPY NUMBER VARIATION; FEMALE; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; NONFUNCTIONING PITUITARY ADENOMA; POINT MUTATION; PRIORITY JOURNAL; PROLACTINOMA;

ACROMEGALY; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; GERM-LINE MUTATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ITALY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE ENDOCRINE NEOPLASIA; PEDIGREE; PREVALENCE; YOUNG ADULT;

EID: 77956297046     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0327     Document Type: Article

References (42)

1. Sanno N, Teramoto A, Osamura RY, Horvath E, Kovacs K, Lloyd RV & Scheithauer BW. Pathology of pituitary tumors. Neurosurgery Clinics of North America 2003 14 25-39.
2. Melmed S. Medical progress: acromegaly. New England Journal of Medicine 2006 355 2558-2573.
3. Al-Shraim M & Asa SL. The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathologica 2006 111 1-7.
4. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR & Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989 340 692-696. (Pubitemid 19214389)
5. Elston MS, McDonald KL, Clifton-Bligh RJ & Robinson BG. Familial pituitary tumor syndromes. Nature Reviews. Endocrinology 2009 5 453-461.
6. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A & Aaltonen LA. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006 312 1228-1230.
7. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wemeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT & Beckers A. Aryl hydrocarbon receptor-interacting protein genemutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism 2007 92 1891-1896.
8. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Mäkinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, Robledo M, De Menis E, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Launonen V, Vahteristo P & Aaltonen LA. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. PNAS 2007 104 4101-4105.
9. Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P, Bertherat J & Raffin-Sanson ML. Germline-inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. European Journal of Endocrinology 2007 157 1-8.
10. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A & Beckers A. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2007 92 1952-1955.
11. Georgitsi M, De Menis E, Cannavò S, Mäkinen MJ, Tuppurainen K, Pauletto P, Curtò L, Weil RJ, Paschke R, Zielinski G, Wasik A, Lubinski J, Vahteristo P, Karhu A & Aaltonen LA. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clinical Endocrinology 2008 69 621-627.
12. Georgitsi M, Heliövaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, Salmela P, Sane T, De Menis E, Cannavò S, Gündogdu S, Lucassen A, Izatt L, Aylwin S, Bano G, Hodgson S, Koch CA, Karhu A & Aaltonen LA. Large genomic deletions in AIP in pituitary adenoma predisposition. Journal of Clinical Endocrinology and Metabolism 2008 93 4146-4151.
13. Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 2006 103 15558-15563.
14. Kip1 mutation in multiple endocrine neoplasia. Journal of Clinical Endocrinology and Metabolism 2007 92 3321-3325.
15. Agarwal SK, Mateo CM & Marx SJ. Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. Journal of Clinical Endocrinology and Metabolism 2009 94 1826-1834.
16. Kip1 mutations. Journal of Clinical Endocrinology and Metabolism 2007 92 1948-1951.
17. Kip1 are a rare cause of multiple endocrine neoplasia type 1. Clinical Endocrinology 2009 70 499-500.
18. Igreja S, Chahal HS, Akker SA, Gueorguiev M, Popovic V, Damjanovic S, Wass JA, Quinton R, Grossman AB & Korbonits M. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and AIP (aryl hydrocarbon receptor-interacting protein) genes in MEN1 syndrome patients without any detectable MEN1 gene mutations. Clinical Endocrinology 2008 70 259-264.
19. Chu IM, Hengst L & Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature Reviews. Cancer 2008 8 253-267. (Pubitemid 351430863)
20. Loeper S & Ezzat S. Acromegaly: re-thinking the cancer risk. Reviews in Endocrine & Metabolic Disorders 2008 9 41-58.
21. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA & Giustina A. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clinical Endocrinology 2006 65 265-273.
22. Occhi G, Jaffrain-Rea ML, Trivellin G, Albiger N, Ceccato F, De Menis E, Angelini M, Ferasin S, Beckers A, Mantero F & Scaroni C. The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? Journal of Endocrinological Investigation 2010 In press.
23. Ye S, Dhillon S, Ke X, Collins AR & Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research 2001 29 E88.
24. Castellsagué E, González S, Nadal M, Campos O, Guinó E, Urioste M, Blanco I, Frebourg T & Capellá G. Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. Clinical Chemistry 2008 54 1132-1140. (Pubitemid 352009689)
25. Trevisson E, Salviati L, Baldoin MC, Toldo I, Casarin A, Sacconi S, Cesaro L, Basso G & Burlina AB. Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Human Mutation 2007 28 694-702. (Pubitemid 47047296)
26. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB & Korbonits M. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2008 93 2390-2401.
27. Vargiolu M, Fusco D, Kurelac I, Dirnberger D, Baumeister R, Morra I, Melcarne A, Rimondini R, Romeo G & Bonora E. The tyrosine kinase receptor RET interacts in vivo with AIP to alter survivin availability. Journal of Clinical Endocrinology and Metabolism 2009 94 2571-2578.
28. Ellard S, Hattersley AT, Brewer CM & Vaidya B. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clinical Endocrinology 2005 62 169-175. (Pubitemid 40203911)
29. Cazabat L, Guillaud-Bataille M, Bertherat J & Raffin-Sanson ML. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas. Hormone Research 2009 71 132-141.
30. Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, Verma S, Daly AF, Raygada M, Keil MF, Papademetriou J, Drori-Herishanu L, Horvath A, Tsang KM, Nesterova M, Franklin S, Vanbellinghen J-F, Bours V, Salvatori R & BeckersA.The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in a large cohort of children and adolescents with pituitary adenomas. Clinical Genetics 2010 In press.
31. Vergès B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C & Calender A. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. Journal of Clinical Endocrinology and Metabolism 2002 87 457-465.
32. Ghataorhe P, Kurian AW, Pickart A, Trapane P, Norton JA, Kingham K & Ford JM. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature. Cancer Genetics and Cytogenetics 2007 179 89-92. (Pubitemid 350116947)
33. Papi L, Palli D, Masi L, Putignano AL, Congregati C, Zanna I, Marini F, Giusti F, Luzi E, Tonelli F, Genuardi M, Brandi ML & Falchetti A. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. Cancer Genetics and Cytogenetics 2009 195 75-79.
34. Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, Hayes FJ, Boepple P, Hall JE, Bouloux P, Mohammadi M & Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. Journal of Clinical Investigation 2007 117 457-463.
35. Delnatte C, Sanlaville D, Mougenot JF, Vermeesch JR, Houdayer C, Blois MC, Genevieve D, Goulet O, Fryns JP, Jaubert F, Vekemans M, Lyonnet S, Romana S, Eng C & Stoppa-Lyonnet D. Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. American Journal of Human Genetics 2006 78 1066-1074.
36. Salviati L, Patricelli M, Guariso G, Sturniolo GC, Alaggio R, Bernardi F, Zuffardi O & Tenconi R. Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy. American Journal of Human Genetics 2006 79 593-596. (Pubitemid 44384271)
37. Hemminki K, Försti A & Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocrine-Related Cancer 2007 14 103-109.
38. Lauter KB & Arnold A. Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary/tertiary hyperparathyroidism. Kidney International 2008 73 1137-1140.
39. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW & Koeffler HP. p27/Kip1 mutation found in breast cancer. Cancer Research 1996 56 2400-2404.
40. Takeuchi S, Koeffler HP, Hinton DR, Miyoshi I, Melmed S & Shimon I. Mutation and expression analysis of the cyclindependent kinase inhibitor gene p27/Kip1 in pituitary tumors. Journal of Endocrinology 1998 157 337-341.
41. Kip1 in human pituitary adenomas. European Journal of Endocrinology 1999 140 250-255.
42. Muşat M, Morris DG, Korbonits M & Grossman AB. Cyclins and their related proteins in pituitary tumourigenesis. Molecular and Cellular Endocrinology 2010 In press.